CA125 Blood Test May Help Alert GPs to Ovarian and Other Cancers, Research Shows

CA125 Blood Test May Help Alert GPs to Ovarian and Other Cancers, Research Shows
Commonly used in primary healthcare, blood tests for CA125 may help diagnose ovarian cancer and other types of cancer, particularly in older individuals, new research suggests. The findings were described in two presentations at the recent 2019 National Cancer Research Institute (NCRI) Conference in Glasgow, UK. The sessions were titled, "The predictive value of CA125 for ovarian cancer in General Practice: a population-based cohort study of over 50,000 women," and "The incidence of non-ovarian cancers in women with elevated CA125 levels in General Practice." "Our work shows that CA125 is a very useful test for detecting ovarian cancer in general practice," Garth Funston, a researcher at the University of Cambridge and co-investigator on the study, said in a press release. "This could help guide decisions made by GPs [general practitioners] and their patients about the need for further investigation or referral." Symptoms of ovarian cancer, such as bloating and abdominal pain, can be fairly non-specific. Blood tests have been proposed as a non-invasive strategy to identify individuals with these symptoms who are more likely to have cancer so that they can be referred for further testin
Subscribe or to access all post and page content.